Assessing Barriers and Increasing Use of Immunization Registries in Pharmacies

Immunization Clinical Trial

Official title:

Assessing Barriers and Increasing Use of Immunization Registries in Pharmacies: A Randomized Controlled Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03796585
• Other study ID #: 1R36HS026093-01A1
• Status: Completed
• Phase: N/A
• Start date: January 10, 2019
• Est. completion date: September 15, 2019

Study information

• Verified date: October 2019
• Source: Auburn University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to identify barriers to utilization of immunization registries within a pharmacy context and tailor the information into a novel immunization registry training program.

Description:

The purpose of this study is to identify barriers to utilization of immunization registries within a pharmacy context and tailor the information learned about barriers into a novel immunization registry training program with strategies specific to individual subsets of pharmacies, independent pharmacies in rural areas. Doing so will help achieve the long-term goal which is to increase the use of immunization registries in community pharmacies in Alabama.

The specific aims are to

1. identify barriers and best practices of immunization registry implementation,

2. use a participatory design approach to develop an immunization registry training program, and

3. disseminate and assess the impact of the immunization registry training program among community pharmacies' registry participation rates.

The impact of the training program on registry participation rates will be assessed using a randomized controlled trial design comparing Alabama community pharmacies' registry data as well as intention to participate.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 52
• Est. completion date: September 15, 2019
• Est. primary completion date: September 15, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 19 Years and older

Eligibility

Inclusion Criteria:

• not currently enrolled in ImmPRINT

• currently provide at least one type of vaccination in addition to influenza

• independently owned

• agree to provide requested data for assessment

Exclusion Criteria:

-

Related Conditions & MeSH terms

• Immunization

Intervention

Behavioral:
• Immunization Registry Training
Education highlighting practical strategies to improve pharmacies' willingness to adopt the immunization registry and improve their ability to integrate the immunization registry into their pharmacy workflow.
• Informational flyer
Informational flyer with ImmPRINT contact information

Locations

Country	Name	City	State
United States	Auburn University	Auburn	Alabama

Sponsors (2)

Lead Sponsor	Collaborator
Auburn University	Agency for Healthcare Research and Quality (AHRQ)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of pharmacies enrolled in the Alabama Immunization Registry	The change in the number of participant pharmacies enrolled in the Alabama immunization registry from baseline to 3 months.	3 months
Secondary	Level of Immunization Registry Participation	Proportion of self-reported doses administered that are verified in the immunization registry.	3 months
Secondary	Change in awareness	The change in participant awareness of immunization registries from baseline to 3 months assessed by online questionnaire at baseline, one month, and three months. Awareness will be measured using three true or false items. Each item will be scored, 0 for an incorrect answer and 1 for a correct answer. Awareness index is the sum of the 3 items and could range from 0-3 with higher values representing greater awareness.	1 month and 3 months
Secondary	Change in knowledge	The extent to which participant is familiar with and understands immunization registries will be assessed via online questionnaire at baseline, one month, and three months. Eight true or false and multiple answer items will be used to measure knowledge. Each item will be scored, 0 for an incorrect answer and 1 for a correct answer. Knowledge is the sum of the 8 items and could range from 0-8 with higher values representing greater knowledge.	1 month and 3 months
Secondary	Change in attitudes	Participant's perceptions toward attributes of the immunization registry assessed via online questionnaire at baseline, one month, and three months. A scale including 25 Likert-type items will be used to measure attitudes. Each Likert-type item will be scored, ranging from 0 for strongly disagree to 6 for strongly agree. Mean scores will be calculated for the 25 items in the scale so that attitudes score range from 0 to 6 with higher values indicating greater positive attitudes.	1 month and 3 months
Secondary	Change in intention to enroll in immunization registry	Participant's likelihood to enroll their pharmacy in the immunization registry assessed via online questionnaire at baseline and one month. A scale including 3 Likert-type items will be used to measure intention. Each Likert-type item will be scored, ranging from 0 for strongly disagree to 6 for strongly agree. Mean scores will be calculated for the three items in the scale so that intention score ranges from 0 to 6 with higher values indicating greater intention.	1 month and 3 months
Secondary	Change in Implementation Factors	Implementation factors informed by the Consolidated Framework for Implementation Research (CFIR) including innovation characteristics, characteristics of individuals, inner setting, outer setting, and process will be assessed via online questionnaire at baseline and three months. A scale including 42 Likert-type items will be used to measure Implementation Factors. Each Likert-type item will be scored, ranging from 0 for strongly disagree to 6 for strongly agree. Mean scores will be calculated so that the implementation factors score ranges from 0 to 6 with higher values indicating greater positive influence of CFIR implementation factors.	3 months